Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Pharma Industry Face Unprecedented Price Pressure in Expanded 4+7 Tender as Gove...
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on MNC performance at the latest expanded 4+7 tender, unprec... (9/30/2019)
   
Xian Janssen: Embrace Better Future with New Solutions (11/19/2019)
Pharmaceutical Innovation in the APAC Region (11/13/2019)
As Trade War Continues, Pharma Companies Prepare for Alternatives (11/13/2019)
A Summary of The Latest Amendments to the Guidelines for Patent Examination In China (11/12/2019)
Restrictions and Conflicts - Challenges Faced by Pharmaceutical Trademarks In China (11/7/2019)
Top Execs from AstraZeneca, Roche, Sanofi and GSK Tout China Investments at Import Expo (11/7/2019)
Finding the Right Formula for China Business Amid Cloudy Outlook (11/4/2019)
Enforcing Patents - China's Bad Faith Entities List (10/31/2019)
Newly Revised Guidelines For Patent Examination Will Come Into Force As Of November 1 (10/31/2019)
In Generic Drug Plants in China and India, Data Falsification Is Still A Problem (10/30/2019)
China's $132 Billion Market Pushes Big Pharma Into Uncharted Territory (10/24/2019)
The Life Sciences Regulatory Regime in China (10/24/2019)
China Is Striving for the World's Best, Cheapest Healthcare (10/22/2019)
China's Blueprint for Its Pharmaceutical Sector (10/16/2019)
China's Drug Administrative Law Amended to Encourage Innovation and Deter Safety Violations (10/16/2019)
MimiVax and Fosun Pharma Announce Licens...  (11/19/2019)
WuXi AppTec's LTD Expands Toxicology Fac...  (11/19/2019)
Novartis Closes Early Drug Discovery R&a...  (11/18/2019)
3SBio Selects Verseau's PSGL-1-targeted ...  (11/18/2019)
Chinese Import of Medicines Up Only 1.6%...  (11/18/2019)
Listed Chinese MedPharm Companies Report...  (11/18/2019)
CNMA Publishes 2019 Top 100 OTC Drug Man...  (11/18/2019)
Former Deputy CFDA Commissioner Sentence...  (11/16/2019)
Hua Medicine Stock Sheds 40% Over Effica...  (11/16/2019)
RemeGen Announces Positive Results from ...  (11/16/2019)
Recent Executive Moves  (11/16/2019)
State Council Announces Promotion of Hea...  (11/15/2019)
CDE Accepts Lilly's NDA for Verzenio (Ab...  (11/15/2019)
U.S. FDA Grants BeiGene's BRUKINSA (zanu...  (11/15/2019)
China to Launch Nationwide Vaccine Track...  (11/14/2019)
Pfizer to Absorb Mylan, Creating Global Generic Powerhou...
PhRMA Calls for Trade Deals That Force Countries to Pay ...
IQVIA: Global Pharma to Grow Slower in the Next Five Yea...
Pfizer and GSK Announce JV to Create a Global Consumer H...
Top 25 Global Pharmaceutical Companies by Market Cap 201...
Chinese Import of Medicines Up Only 1.6% in 3Qs/2019
Outlook on Chinese Pharma Distribution Market 2019-2025
Global and Chinese OTC Market Growth Slows in MAT Q2/2019
SMEI: Chinese County Level Public Hospital Drug Sales Up 7.8% i...
SMEI: Chinese Township Health Center Drug Sales Up 9.3% in 2018...
MimiVax and Fosun Pharma Announce Licensing Deal for Gliobla...
WuXi AppTec's LTD Expands Toxicology Facility in China
Novartis Closes Early Drug Discovery R&D Unit in China
3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 As...
Listed Chinese MedPharm Companies Report Slower Growth in Q3...
China to Launch Nationwide Vaccine Tracking System Next ...
CDE Solicits Comments on the Working Procedures for Risk...
NMPA Announces Implementation of 15 Series E and 13 Seri...
CDE Extends Deadline for Public Comments on Nine Draft D...
CDE Solicits Comments on the Technical Guidelines for Cl...
CNIPA Issues Administrative Measures on List of Serious Viol...
Centrient Pharma Initiates a Second Patent Litigation in Ind...
Couple Stole Trade Secrets from U.S. Children's Hospital to ...
China Adopts New Amendment of PRC Drug Administration Law
New Revision Draft of Drug Administration Law Submitted to t...
Nikkei: Japan's Generic Drugmakers Have A China Dependen...
Korea's Growing Reliance on China for API Supply Flagged...
WuXi STA's Jinshan Facility Passes EMA Inspection
Novartis Disposes Suzhou Novartis PharmTech in Changshu ...
FDA Warns Chinese API Producer Yino
RemeGen Announces Positive Results from Phase IIb Trial ...
CDE Accepts Lilly's NDA for Verzenio (Abemaciclib)
U.S. FDA Grants BeiGene's BRUKINSA (zanubrutinib) Accele...
Hua Medicine's Pivotal Phase III Monotherapy Trial of Do...
Chi-Med Announces NDA Acceptance for Novel Drug Surufati...
State Council Announces Promotion of Healthcare Reform E...
China Issues the Provisions for Health Insurance Adminis...
NHSA Initiates A New Round of Negotiation for the NRDL A...
NDRC Issues the Work Plan for Building Regional Medical ...
NHC Issues Notice to Establish National and Regional Men...
Former Deputy CFDA Commissioner Sentenced to 16 Years in P...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Sino Biopharma Founders Makes Son Eric Tse A Major Shareho...
Upcoming Event: Asia Wellness Expo 2020
Upcoming Event: NanoPharma 2020
Upcoming Event: IDF Congress 2019
Upcoming Event: Phar-East 2020
Upcoming Event: 2019 Pharma CI+MR Asia Conference &a...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Publishes the China Phar...
  WiCON to Hold Pharma China Ann...
  WiCON Publishes the China Phar...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links